United States · 
Who invested in ConsejoSano?
ConsejoSano's investors include Acumen, Impact Engine, Oxeon, 7wire Ventures/ Tufts Health and TOTAL Impact, and 1 more on record.
United States · Series A startup
Who invested in ConsejoSano
Funding summaryUpdated 26 Oct 2026
$4.9Mraised across 1 round since 2017, from 1 source
- Latest round
- Series A, $4.9MFeb 2017
- Investors
- 6
The rounds
- Feb 2017Series A$4.9M
Acumen
Impact Engine
Oxeon- 7wire Ventures/ Tufts Health
- TOTAL Impact
- Wanxiang
Reported by MobihealthnewsSEC filing: $1.0M sold, first sale Jan 2017
Founders and team
From the SEC filings it signed: 2 on the team.
- Abner MasonCEO, President and Secretaryi
- Vikram D. BakhruChief Operating Officer and Chief Financial Officeri
On the board, as filediChristine AylwardMolly CoyeRobert Garber
Everyone who backed them
7wire Ventures/ Tufts Healthno record of our own yet1round
TOTAL Impactno record of our own yet1round
Wanxiangno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists ConsejoSano as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about ConsejoSano
How much has ConsejoSano raised?
ConsejoSano has raised $4.9M across 1 round since 2017.
When did ConsejoSano last raise?
ConsejoSano's most recent round was a Series A of $4.9M in Feb 2017.
What was ConsejoSano's biggest round?
Its most recent round, $4.9M in Feb 2017, is also its largest on record.
Who backed ConsejoSano first?
ConsejoSano's first round on record, in Feb 2017, was backed by Acumen, Impact Engine and Oxeon and 3 others.
What stage is ConsejoSano at?
ConsejoSano's latest named round is a Series A, in Feb 2017.
Where is ConsejoSano based?
ConsejoSano is based in the United States.
Companies like ConsejoSano
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.